Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer.
about
Esophageal cancer: Recent advances in screening, targeted therapy, and managementCirculating antibodies to p16 protein-derived peptides in breast cancerFurther study of circulating IgG antibodies to CD25-derived peptide antigens in nonsmall cell lung cancerCirculating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy.A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer.Circulating anti-p16a IgG autoantibodies as a potential prognostic biomarker for non-small cell lung cancer
P2860
Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Anti-p16 autoantibodies may be ...... iagnosis of esophageal cancer.
@en
Anti-p16 autoantibodies may be ...... iagnosis of esophageal cancer.
@nl
type
label
Anti-p16 autoantibodies may be ...... iagnosis of esophageal cancer.
@en
Anti-p16 autoantibodies may be ...... iagnosis of esophageal cancer.
@nl
prefLabel
Anti-p16 autoantibodies may be ...... iagnosis of esophageal cancer.
@en
Anti-p16 autoantibodies may be ...... iagnosis of esophageal cancer.
@nl
P2093
P2860
P356
P1476
Anti-p16 autoantibodies may be ...... diagnosis of esophageal cancer
@en
P2093
Kuang-Hui Lee
Shilong Sun
Songlei Guan
Yonglong Jin
P2860
P304
P356
10.1111/AJCO.12198
P50
P577
2014-05-09T00:00:00Z